Pulmonx (LUNG) Insider Trading & Ownership $6.79 +0.37 (+5.76%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Pulmonx (NASDAQ:LUNG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.70%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$97,435.80Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$1.35 M Get LUNG Insider Trade Alerts Want to know when executives and insiders are buying or selling Pulmonx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LUNG Insider Buying and Selling by Quarter Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Pulmonx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/17/2024Glendon E French IIIDirectorSell20,000$6.52$130,400.00 9/12/2024Glendon E French IIIDirectorSell20,000$8.09$161,800.00 9/3/2024David Aaron LehmanGeneral CounselSell5,765$6.69$38,567.85 9/3/2024Geoffrey Beran RoseInsiderSell4,586$6.70$30,726.20 8/20/2024Steven S WilliamsonCEOBuy14,245$6.84$97,435.80 6/24/2024Geoffrey Beran RoseInsiderSell1,184$6.16$7,293.44 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/3/2024David Aaron LehmanGeneral CounselSell5,475$6.97$38,160.75 6/3/2024Geoffrey Beran RoseInsiderSell4,297$6.97$29,950.09 5/22/2024Geoffrey Beran RoseInsiderSell1,184$8.71$10,312.64 4/22/2024Geoffrey Beran RoseInsiderSell1,184$7.49$8,868.16 3/22/2024Geoffrey Beran RoseInsiderSell1,184$9.36$11,082.24 3/1/2024David Aaron LehmanGeneral CounselSell4,351$9.06$39,420.06 3/1/2024Geoffrey Beran RoseInsiderSell3,097$9.06$28,058.82 3/1/2024Glendon E French IIICEOSell6,954$9.06$63,003.24 3/1/2024John MckuneCFOSell1,078$9.06$9,766.68 2/22/2024Geoffrey Beran RoseInsiderSell1,184$14.20$16,812.80 2/15/2024Glendon E French IIICEOSell20,000$14.60$292,000.00 1/22/2024Geoffrey Beran RoseInsiderSell1,184$13.13$15,545.92 1/18/2024Glendon E French IIICEOSell10,000$12.77$127,700.00 12/22/2023Geoffrey Beran RoseInsiderSell1,184$12.75$15,096.00 12/21/2023Glendon E French IIICEOSell10,000$12.42$124,200.00 12/1/2023David Aaron LehmanGeneral CounselSell3,809$10.34$39,385.06 12/1/2023Geoffrey Beran RoseInsiderSell2,868$10.34$29,655.12 12/1/2023Glendon E French IIICEOSell6,676$10.34$69,029.84 12/1/2023John MckuneCFOSell942$10.34$9,740.28 (Data available from 1/1/2013 forward) LUNG Insider Trading Activity - Frequently Asked Questions Who is on Pulmonx's Insider Roster? The list of insiders at Pulmonx includes Alissa Hsu Lynch, David Aaron Lehman, Derrick Sung, Geoffrey Beran Rose, Glendon E French III, John Mckune, Richard Ferrari, and Steven S Williamson. Learn more on insiders at LUNG. What percentage of Pulmonx stock is owned by insiders? 5.70% of Pulmonx stock is owned by insiders. Learn more on LUNG's insider holdings. Which Pulmonx insiders have been buying company stock? The following insiders have purchased LUNG shares in the last 24 months: Alissa Hsu Lynch ($9,367.00), and Steven S Williamson ($97,435.80). How much insider buying is happening at Pulmonx? Insiders have purchased a total of 15,945 LUNG shares in the last 24 months for a total of $106,802.80 bought. Which Pulmonx insiders have been selling company stock? The following insiders have sold LUNG shares in the last 24 months: David Aaron Lehman ($242,979.09), Derrick Sung ($104,642.70), Geoffrey Beran Rose ($331,438.79), Glendon E French III ($1,478,930.87), and John Mckune ($19,506.96). How much insider selling is happening at Pulmonx? Insiders have sold a total of 213,779 Pulmonx shares in the last 24 months for a total of $2,177,498.41 sold. Pulmonx Key ExecutivesMr. David A. Lehman (Age 63)General Counsel & Secretary Compensation: $651.39k2 recent tradesMr. Geoffrey Beran Rose (Age 50)Chief Commercial Officer Compensation: $632.29k3 recent tradesMr. Steven S. Williamson (Age 51)CEO, President & Director 1 recent tradesMr. Mehul Joshi (Age 63)Chief Financial Officer Mr. Sri RadhakrishnanChief Technical OfficerMs. Marcee M. Maroney (Age 54)Vice President of Marketing Sarah HuberVice President of Sales (U.S.)Ms. Lisa Paul (Age 60)Chief People Officer Mr. Jérôme ErathSenior VP & GM of Europe Middle-East & AfricaMr. John B. McKune (Age 48)VP & Corporate Controller More Insider Trading Tools from MarketBeat Related Companies Cerus Insider Buying Inovio Pharmaceuticals Insider Buying Atrion Insider Buying Pulse Biosciences Insider Buying Bioventus Insider Buying National Vision Insider Buying Paragon 28 Insider Buying Liquidia Insider Buying Avanos Medical Insider Buying Embecta Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:LUNG) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
